Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander van Deventer

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|March 4, 2011
Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapySander van der Marel, Elisabeth M Comijn, Hein W Verspaget, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacyPiotr Maczuga, Jacek Lubelski, Richard van Logtenstein, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidationJosep M Orellana-Gavaldà, Laura Herrero, Maria Ida Malandrino, et al.
Brain : a Journal of Neurology|August 18, 2024
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease modelsMarina Sogorb-Gonzalez, Christian Landles, Nicholas S Caron, et al.
British Journal of Clinical Pharmacology|March 18, 2014
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsJohn Ford, Matt Lawson, David Fowler, et al.
Human Gene Therapy|May 8, 2009
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both gendersAstrid Pañeda, Lucia Vanrell, Itsaso Mauleon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's diseaseAnne Corbaz, Tessa ten Hove, Suzanne Herren, et al.
The New England Journal of Medicine|November 4, 2005
Natalizumab induction and maintenance therapy for Crohn's diseaseWilliam J Sandborn, Jean Frédéric Colombel, Roberts Enns, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2019
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph DiseaseRaygene Martier, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1Lucía Gil-Guerrero, Javier Dotor, Inge Louise Huibregtse, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|March 4, 2011
Neutralizing antibodies against adeno-associated viruses in inflammatory bowel disease patients: implications for gene therapySander van der Marel, Elisabeth M Comijn, Hein W Verspaget, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 24, 2012
Embedding siRNA sequences targeting apolipoprotein B100 in shRNA and miRNA scaffolds results in differential processing and in vivo efficacyPiotr Maczuga, Jacek Lubelski, Richard van Logtenstein, et al.
Hepatology (Baltimore, Md.)|February 15, 2011
Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidationJosep M Orellana-Gavaldà, Laura Herrero, Maria Ida Malandrino, et al.
Brain : a Journal of Neurology|August 18, 2024
Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington's disease modelsMarina Sogorb-Gonzalez, Christian Landles, Nicholas S Caron, et al.
British Journal of Clinical Pharmacology|March 18, 2014
Tolerability, pharmacokinetics and pharmacodynamics of TA-8995, a selective cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjectsJohn Ford, Matt Lawson, David Fowler, et al.
Human Gene Therapy|May 8, 2009
Effect of adeno-associated virus serotype and genomic structure on liver transduction and biodistribution in mice of both gendersAstrid Pañeda, Lucia Vanrell, Itsaso Mauleon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's diseaseAnne Corbaz, Tessa ten Hove, Suzanne Herren, et al.
The New England Journal of Medicine|November 4, 2005
Natalizumab induction and maintenance therapy for Crohn's diseaseWilliam J Sandborn, Jean Frédéric Colombel, Roberts Enns, et al.
Molecular Therapy. Methods & Clinical Development|December 13, 2019
Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph DiseaseRaygene Martier, Marina Sogorb-Gonzalez, Janice Stricker-Shaver, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
In vitro and in vivo down-regulation of regulatory T cell activity with a peptide inhibitor of TGF-beta1Lucía Gil-Guerrero, Javier Dotor, Inge Louise Huibregtse, et al.
Pageof 4